You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Suberoylanilide Hydroxamic Acid

Showing 1 - 25 of 8,024
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Intrinsic Pontine Glioma Trial in Houston (Radiation Therapy, Temsirolimus, Vorinostat)

Active, not recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Radiation Therapy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 5, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Prognostic Stage IV Breast Cancer AJCC v8
  • Pembrolizumab
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 5, 2023

Adult Solid Tumor Trial in Chicago (Carboplatin, Laboratory Biomarker Analysis, Paclitaxel)

Active, not recruiting
  • Adult Solid Neoplasm
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 25, 2023

Advanced Cancers Trial in Houston (MLN9708, Vorinostat)

Completed
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 8, 2022

Prostate Cancer, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer Trial in Baltimore, Buffalo (drug, other,

Terminated
  • Prostate Cancer
  • +4 more
  • Baltimore, Maryland
  • +1 more
Sep 30, 2022

Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in New York, Nashville (Laboratory Biomarker Analysis,

Active, not recruiting
  • Metastatic Uveal Melanoma
  • Stage IV Uveal Melanoma AJCC v7
  • New York, New York
  • +2 more
Jun 29, 2022

Malignant Solid Tumour Trial in San Antonio (Hydroxychloroquine, Vorinostat)

Active, not recruiting
  • Malignant Solid Tumour
  • San Antonio, Texas
    Cancer Therapy & Research Center University of Texas Health Scie
Dec 13, 2021

Relapsed or Refractory Multiple Myeloma Trial (Vorinostat, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Oct 27, 2020

Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Bronx, New York (vorinostat,

Terminated
Has Results
  • Recurrent Renal Cell Cancer
  • +2 more
  • Bronx, New York
  • +1 more
Feb 1, 2021

Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer Trial in Richmond (drug, radiation, other)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • +6 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Oct 20, 2021

Advanced Cancers Trial in Houston (Hydroxychloroquine, Sirolimus, Vorinostat)

Completed
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2021

Relapsed or Refractory Multiple Myeloma Trial (Vorinostat, Bortezomib, Dexamethasone)

Completed
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Mar 5, 2021

Recurrent DLBCL, Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory DLBCL Trial in Houston (drug, procedure, other, biological)

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Lymphoma, Solid Tumor Trial in Rockledge (drug, procedure, other)

Completed
Has Results
  • Lymphoma
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Rockledge, Pennsylvania
    Fox Chase Cancer Center
Feb 2, 2021

Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx

Active, not recruiting
Has Results
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2022

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell

Completed
  • Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • Allogeneic Bone Marrow Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 15, 2021

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022

Glioblastoma Multiforme, Anaplastic Glioma Trial in Houston (Vorinostat, Isotretinoin, Surgical Resection)

Active, not recruiting
  • Glioblastoma Multiforme
  • Anaplastic Glioma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 29, 2020

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Nov 17, 2023

Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer Trial in Baltimore (vorinostat, conventional surgery)

Completed
Has Results
  • Breast Cancer
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Feb 7, 2020

Multiple Myeloma, Plasma Cell Tumor Trial in Columbus (lenalidomide, vorinostat)

Completed
  • Multiple Myeloma
  • Plasma Cell Neoplasm
  • Columbus, Ohio
    Ohio State University
May 14, 2020

Advanced Cancer Trial in Houston (Sirolimus, Vorinostat, Everolimus)

Unknown status
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 10, 2020

Recurrent Oral Cavity Adenoid Cystic Carcinoma, Recurrent Salivary Gland Carcinoma, Salivary Gland Adenoid Cystic Carcinoma

Completed
Has Results
  • Recurrent Oral Cavity Adenoid Cystic Carcinoma
  • +11 more
  • Duarte, California
  • +11 more
Jul 14, 2020

Medulloblastoma, Pineoblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified Trial in United States (radiation, drug,

Completed
  • Medulloblastoma
  • +2 more
  • 3-Dimensional Conformal Radiation Therapy
  • +10 more
  • Los Angeles, California
  • +14 more
Jan 12, 2022

Advanced Cancers, Lymphoma Trial in Houston (Azacitidine, Vorinostat, Gemcitabine)

Completed
Has Results
  • Advanced Cancers
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 14, 2020